Kelly R McMahon, Shahrad Rod Rassekh, Kirk R Schultz, Tom Blydt-Hansen, Geoffrey D E Cuvelier, Cherry Mammen, Maury Pinsk, Bruce C Carleton, Ross T Tsuyuki, Colin J D Ross, Ana Palijan, Louis Huynh, Mariya Yordanova, Frédérik Crépeau-Hubert, Stella Wang, Debbie Boyko, Michael Zappitelli
Importance: Few multicenter pediatric studies have comprehensively described the epidemiologic characteristics of cisplatin-associated acute kidney injury using standardized definitions. Objective: To examine the rate of and risk factors associated with acute kidney injury among children receiving cisplatin infusions. Design, Setting, and Participants: This prospective cohort study examined children (aged <18 years) recruited from May 23, 2013, to March 31, 2017, at 12 Canadian pediatric academic health centers who were receiving 1 or more cisplatin infusion...
May 1, 2020: JAMA Network Open